Ameris Ban
High‑ROA Southeast Franchise With Guardrails and Optionality
Ameris Bancorp operates a growing, relationship‑driven regional bank across attractive Southeast markets with a balanced mix of low‑cost core deposits, disciplined credit, and fee income from mortgage and specialty lending.
Recent results show improving profitability metrics: net interest margin expanded to 3.88% in Q1 2026, efficiency improved to ~50%, and ROA/ROTCE reached 1.62%/14.75%. Tangible book per share rose to $44.79 while tangible common equity to tangible assets stayed robust at ~11%.
Credit costs and nonperformers remain low, and capital ratios are comfortably above internal targets. The franchise’s structural strengths are its granular deposit base in fast‑growing metros, consistent noninterest‑bearing mix near 30%, and limited reliance on noncore funding.
Management continues to return capital through buybacks while redeeming higher‑cost sub debt, all without compromising capital levels. That said, this is still a bank: cyclicality in credit and deposit pricing, mortgage fee variability, and CRE concentration governance require vigilance.
Valuation should be anchored to steady state earnings and tangible book compounding; on our TTM owner‑earnings base we estimate a fair multiple of ~11.5x, implying a per‑share fair value around the low‑to‑mid 70s with a margin‑of‑safety discipline.
Does Ameris Ban have a strong competitive moat?
Moat components and weights: cost advantage from core deposits (35%), efficient local scale in attractive metros (25%), switching costs/relationships (20%), brand/intangibles (15%), network effects (5%).
Cost advantage: deposit mix is consistently favorable, with noninterest‑bearing deposits around 30% and brokered CDs only ~5% in 3Q25, contributing to a total cost of funds below 2% recently. This helps sustain an above‑peer margin even as rates move.
Efficient scale: Ameris ranks among the top share holders in several Southeast MSAs (e.g., Atlanta, Jacksonville, Savannah for banks under $50B), conferring local density benefits and operating leverage.
Switching costs: treasury and cash‑management relationships and mortgage/specialty verticals deepen ties, but switching costs in retail and many SMB accounts are moderate. Brand: regionally recognized but not national. Network effects: limited in banking.
Holistically, the moat is real but not impregnable; tech‑enabled competitors and deposit pricing cycles can erode advantages, so we cap the score in the low 60s.
Does Ameris Ban have pricing power in its industry?
Pricing power shows through stable‑to‑rising net interest margin and the ability to lower deposit costs while maintaining growth. NIM reached 3.88% in Q1 2026, with deposit costs falling 11 bps sequentially to 1.76% as noninterest‑bearing mix improved.
Fee income from mortgage, SBA, equipment/premium finance and service charges provides incremental monetization of relationships. Still, banks lack true unilateral pricing power; competitive deposit markets and regulatory constraints tighten spreads.
Management also guides to slight near‑term margin compression if deposit costs re‑firm to fund asset growth. Score reflects decent but cyclical pricing capability rather than monopoly‑like power.
How predictable is Ameris Ban's business?
Ameris exhibits relatively steady growth and profitability across rate cycles. TTM diluted EPS approximates $6.36 (Q2‑25 through Q1‑26), with ROA ~1.6% and ROTCE ~14–15% in Q1 2026. Credit remains benign: ACL 1.62% of loans, NPA ~0.45% of assets (0.33% ex‑GNMA) and NCOs ~0.21% annualized.
Deposits and loans grew mid‑single digits annualized in Q1 2026. Offsets: fee income from mortgage can be variable with rates, and CRE exposure requires ongoing governance. Diversification into mortgage warehouse, SBA and premium finance helps, but macro and regulatory factors can swing outcomes more than in toll‑like businesses.
Is Ameris Ban financially strong?
Capital and liquidity are strong. CET1 around 13% and TCE/TA ~11% provide a substantial cushion above internal targets. ACL coverage is 1.62% of loans, with low NPAs and NCOs.
Uninsured deposits were estimated at ~$10.37 billion at 9/30/25 (of which ~27.6% were collateralized municipal deposits), and Ameris maintained sizable contingent liquidity lines (FHLB and FRB combined >$5 billion as of 3Q25), alongside a growing AFS portfolio.
Loan‑to‑deposit ratio runs mid‑90s, consistent with efficient but not stretched balance‑sheet usage. These metrics support resilience under stress scenarios.
How effective is Ameris Ban's capital allocation strategy?
Management prioritizes organic growth, efficiency, and disciplined capital return.
In 2025 Ameris redeemed subordinated debt that aided NIM expansion; it repurchased ~$77 million of stock in 2025 and ~$75 million in Q1 2026 while growing tangible book per share 14.5% in 2025 and a further 5.6% annualized in Q1 2026. Dividend is modest ($0.20 quarterly), leaving capacity for reinvestment and buybacks.
Stock‑based compensation is primarily in restricted stock/PSUs, and share count has been trending down with buybacks. M&A is not a near‑term priority, reducing integration risk. Overall, capital deployment has enhanced per‑share value without weakening capital.
Does Ameris Ban have high-quality management?
CEO H. Palmer Proctor and CFO Nicole Stokes have steered the company through a higher‑rate environment while improving operating leverage and capital metrics.
Public commentary emphasizes organic growth, deposit quality, and cautious use of noncore funding, with clear guardrails on CRE concentrations (CRE ~265% and construction ~46% of risk‑based capital at Q1 2026). The executive team’s tenure and communication are solid, and governance materials are accessible.
We score this above average, noting execution so far on efficiency and risk controls.
Is Ameris Ban a quality company?
Ameris Ban is a good quality company with a quality score of 72/100
- Core funding quality: noninterest‑bearing deposits were 29.8% of total at March 31, 2026; brokered CDs were ~5% of deposits in 3Q25, supporting a structurally better cost of funds.
- Profitability trending up: net interest margin expanded to 3.88% in Q1 2026 and efficiency ratio improved to ~50%, with fee income near 22% of revenue.
- Strong capital and credit: CET1 near ~13%, TCE/TA ~11%, ACL at 1.62% of loans, NPA ~0.45% of assets and NCOs running ~0.21% annualized in Q1 2026.
- CRE/office risk is governed: non‑owner‑occupied office ~6.5% of loans with low problem ratios, ~58% average LTV and ~1.63x DSCR; CRE concentration ~261% of risk‑based capital at 3Q25.
- Shareholder alignment: ongoing buybacks ($77m in 2025; ~$75m in Q1 2026) and sub‑debt redemptions improved per‑share compounding without weakening capital.
What is the fair value of Ameris Ban stock?
Is Ameris Ban a good investment at $85?
The following analysis is provided for informational and educational purposes only. It does not constitute financial advice, investment advice, or a recommendation to buy or sell any security. The opinions expressed are based on publicly available information and historical data. Beanvest and its contributors may hold positions in the securities mentioned. Investors should conduct their own due diligence or consult a licensed financial advisor before making any investment decision.